Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyHematopoietic Stem CellsBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsLeukocytes, MononuclearGraft vs Host DiseaseMyeloablative AgonistsBusulfanTreatment OutcomeBone Marrow TransplantationGraft SurvivalLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionStem CellsRecurrenceCytophagocytosisHematopoiesisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisCord Blood Stem Cell TransplantationCytarabineHodgkin DiseaseTransplantation ChimeraDisease-Free SurvivalNeoplasmsTissue DonorsRetrospective StudiesTime FactorsSurvival RateWhole-Body IrradiationInfectionSurvival AnalysisLymphoma, T-CellHistocompatibilityDoxorubicinPlatelet CountHistocompatibility TestingImmunosuppressive AgentsBlood CellsPOEMS SyndromeT-LymphocytesRecombinant ProteinsLeukemia, Myeloid, AcutePrednisoneBlood Cell CountLeukemiaCarboplatinTransplantation, IsogeneicCells, CulturedDexamethasoneFlow CytometryVidarabineFollow-Up StudiesImmunophenotypingAntineoplastic AgentsLymphomaCytomegalovirus InfectionsBone Marrow PurgingProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesBone MarrowCell SeparationLymphocytesAntigens, CDMyelodysplastic SyndromesLymphocyte ActivationAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHLA AntigensBone Marrow CellsBlood Transfusion, AutologousLiver TransplantationLeukocyte CountBlood DonorsHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaMonocytes